MALLINCKRODT SALES FORCE RESTRUCTURING WILL CENTRALIZE
MALLINCKRODT SALES FORCE RESTRUCTURING WILL CENTRALIZE the Mallinckrodt Medical sales efforts in a "unified sales organization to be led by a senior executive," the Mallinckrodt Group announced June 15. Mallinckrodt will replace its current structure of five sales units based in disease categories with a single division to "be divided into geographic districts, each headed by a business manager to which a team of account managers and clinical specialists will report," the company said.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth